Atlas Trials

Benralizumab Initiated During Severe Asthma Attack

Clinical trial NCT04617171 · UNKNOWN

Trial details

NCT number
NCT04617171
Sponsor
Singapore General Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Asthma AttackAsthma
Start date
2021-06-02
Primary completion
2023-08-01
Enrollment
128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.